Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
April 2014
|
| In: |
European journal of cancer
Year: 2014, Jahrgang: 50, Heft: 6, Pages: 1137-1147 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2014.01.012 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2014.01.012
|
| Verfasserangaben: | Jean-Yves Blay, Michael G. Leahy, Binh Bui Nguyen, Shreyaskumar R. Patel, Peter Hohenberger, Armando Santoro, Arthur P. Staddon, Nicolas Penel, Sophie Piperno-Neumann, Andrew Hendifar, Pilar Lardelli, Antonio Nieto, Vicente Alfaro, Sant P. Chawla |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1532789092 | ||
| 003 | DE-627 | ||
| 005 | 20220812190151.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160324s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2014.01.012 |2 doi | |
| 035 | |a (DE-627)1532789092 | ||
| 035 | |a (DE-576)462789098 | ||
| 035 | |a (DE-599)BSZ462789098 | ||
| 035 | |a (OCoLC)1340904436 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Blay, Jean-Yves |e VerfasserIn |0 (DE-588)1093882557 |0 (DE-627)853900744 |0 (DE-576)462789187 |4 aut | |
| 245 | 1 | 0 | |a Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas |c Jean-Yves Blay, Michael G. Leahy, Binh Bui Nguyen, Shreyaskumar R. Patel, Peter Hohenberger, Armando Santoro, Arthur P. Staddon, Nicolas Penel, Sophie Piperno-Neumann, Andrew Hendifar, Pilar Lardelli, Antonio Nieto, Vicente Alfaro, Sant P. Chawla |
| 264 | 1 | |c April 2014 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 24.03.2016 | ||
| 700 | 1 | |a Hohenberger, Peter |d 1953- |e VerfasserIn |0 (DE-588)1025311469 |0 (DE-627)72202875X |0 (DE-576)370195574 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 50(2014), 6, Seite 1137-1147 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas |
| 773 | 1 | 8 | |g volume:50 |g year:2014 |g number:6 |g pages:1137-1147 |g extent:11 |a Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejca.2014.01.012 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160324 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 1025311469 |a Hohenberger, Peter |m 1025311469:Hohenberger, Peter |d 60000 |d 61800 |e 60000PH1025311469 |e 61800PH1025311469 |k 0/60000/ |k 1/60000/61800/ |p 5 | ||
| 999 | |a KXP-PPN1532789092 |e 290440810X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Jean-Yves Blay, Michael G. Leahy, Binh Bui Nguyen, Shreyaskumar R. Patel, Peter Hohenberger, Armando Santoro, Arthur P. Staddon, Nicolas Penel, Sophie Piperno-Neumann, Andrew Hendifar, Pilar Lardelli, Antonio Nieto, Vicente Alfaro, Sant P. Chawla"]},"language":["eng"],"recId":"1532789092","type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"corporate":[{"role":"isb","display":"European Organization for Research on Treatment of Cancer"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"disp":"Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomasEuropean journal of cancer","origin":[{"dateIssuedKey":"1992","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","publisher":"Elsevier ; Pergamon Press","dateIssuedDisp":"1992-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"titleAlt":[{"title":"EJC online"}],"pubHistory":["28.1992 -"],"part":{"extent":"11","pages":"1137-1147","volume":"50","issue":"6","year":"2014","text":"50(2014), 6, Seite 1137-1147"},"id":{"issn":["1879-0852"],"eki":["266883400"],"zdb":["1468190-0"]},"recId":"266883400"}],"note":["Gesehen am: 24.03.2016"],"title":[{"title_sort":"Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas","title":"Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas"}],"person":[{"family":"Blay","role":"aut","given":"Jean-Yves","display":"Blay, Jean-Yves"},{"display":"Hohenberger, Peter","role":"aut","given":"Peter","family":"Hohenberger"}],"origin":[{"dateIssuedDisp":"April 2014","dateIssuedKey":"2014"}],"id":{"doi":["10.1016/j.ejca.2014.01.012"],"eki":["1532789092"]}} | ||
| SRT | |a BLAYJEANYVRANDOMISED2014 | ||